GRIFOLS | GRF - Current Liabilities



GRIFOLS reported EUR1.99B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Alcon AG USD 2.42B 178M Jun/2025
Almirall EUR 298.52M 36.18M Jun/2025
Amadeus IT EUR 2.36B 180.1M Jun/2025
Amarin USD 162.41M 17.54M Mar/2025
argenx SE 1.04B 371.99M Jun/2025
AstraZeneca USD 33.54B 4.41B Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Cie Automotive EUR 1.94B 47.91M Dec/2024
Demant DKK 5.79B 301M Jun/2025
Ence Energia y Celulosa EUR 464.6M 41.8M Jun/2025
Essilor EUR 11.39B 832M Jun/2025
Ferrovial EUR 5.98B 323M Jun/2025
Fresenius EUR 8.3B 33M Jun/2025
Fresenius Medical Care EUR 5.66B 213.7M Jun/2025
Galapagos EUR 402.95M 34.09M Jun/2025
Genmab DKK 629M 127M Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
GRIFOLS EUR 1.99B 180.07M Jun/2025
Hikma Pharmaceutical USD 1.98B 598M Dec/2024
Inditex EUR 12.06B 1.87B Apr/2025
Merck EUR 9.86B 357M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Philips EUR 7.2B 445M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sanofi 29.06B 3.16B Jun/2025
Smith & Nephew USD 1.54B 10M Jun/2025
UCB EUR 3.53B 731M Dec/2024
Viscofan EUR 417.29M 25.74M Jun/2025